190 related articles for article (PubMed ID: 29398324)
1. Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ.
Maxwell AJ; Clements K; Hilton B; Dodwell DJ; Evans A; Kearins O; Pinder SE; Thomas J; Wallis MG; Thompson AM;
Eur J Surg Oncol; 2018 Apr; 44(4):429-435. PubMed ID: 29398324
[TBL] [Abstract][Full Text] [Related]
2. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
3. Breast carcinoma in sclerosing adenosis: a clinicopathological and immunophenotypical analysis on 206 lesions.
Yu BH; Tang SX; Xu XL; Cheng YF; Bi R; Shui RH; Tu XY; Lu HF; Zhou XY; Yang WT
J Clin Pathol; 2018 Jun; 71(6):546-553. PubMed ID: 29436376
[TBL] [Abstract][Full Text] [Related]
4. Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
Pilewskie M; Stempel M; Rosenfeld H; Eaton A; Van Zee KJ; Morrow M
Ann Surg Oncol; 2016 Oct; 23(11):3487-3493. PubMed ID: 27172775
[TBL] [Abstract][Full Text] [Related]
5. Ductal Carcinoma In Situ - Quo Vadis?
Peltecu G
Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S5-S6. PubMed ID: 34967322
[TBL] [Abstract][Full Text] [Related]
6. Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study.
Maxwell AJ; Hilton B; Clements K; Dodwell D; Dulson-Cox J; Kearins O; Kirwan C; Litherland J; Mylvaganam S; Provenzano E; Pinder SE; Sawyer E; Shaaban AM; Sharma N; Stobart H; Wallis MG; Thompson AM
Breast; 2022 Feb; 61():145-155. PubMed ID: 34999428
[TBL] [Abstract][Full Text] [Related]
7. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
8. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
van Luijt PA; Heijnsdijk EA; Fracheboud J; Overbeek LI; Broeders MJ; Wesseling J; den Heeten GJ; de Koning HJ
Breast Cancer Res; 2016 May; 18(1):47. PubMed ID: 27160733
[TBL] [Abstract][Full Text] [Related]
9. Women with Low-Risk DCIS Eligible for the LORIS Trial After Complete Surgical Excision: How Low Is Their Risk After Standard Therapy?
Pilewskie M; Olcese C; Patil S; Van Zee KJ
Ann Surg Oncol; 2016 Dec; 23(13):4253-4261. PubMed ID: 27766556
[TBL] [Abstract][Full Text] [Related]
10. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.
Kerlikowske K; Molinaro A; Cha I; Ljung BM; Ernster VL; Stewart K; Chew K; Moore DH; Waldman F
J Natl Cancer Inst; 2003 Nov; 95(22):1692-702. PubMed ID: 14625260
[TBL] [Abstract][Full Text] [Related]
11. Can tumor-associated macrophages in ductal carcinoma in situ on biopsy predict invasive carcinoma on excision?
Hoskoppal D; Reisenbichler ES
Hum Pathol; 2018 Dec; 82():158-162. PubMed ID: 30067949
[TBL] [Abstract][Full Text] [Related]
12. Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus.
Wahedna Y; Evans AJ; Pinder SE; Ellis IO; Blamey RW; Geraghty JG
Eur J Cancer; 2001 Mar; 37(4):459-62. PubMed ID: 11267854
[TBL] [Abstract][Full Text] [Related]
13. Is there a low-grade precursor pathway in breast cancer?
King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
[TBL] [Abstract][Full Text] [Related]
14. Prediction of the presence of invasive disease from the measurement of extent of malignant microcalcification on mammography and ductal carcinoma in situ grade at core biopsy.
O'Flynn EA; Morel JC; Gonzalez J; Dutt N; Evans D; Wasan R; Michell MJ
Clin Radiol; 2009 Feb; 64(2):178-83. PubMed ID: 19103348
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for invasive cancer in surgical specimens following an initial diagnosis of ductal carcinoma in situ after stereotactic vacuum-assisted breast biopsy in microcalcification-only lesions.
Gümüş H; Mills P; Fish D; Gümüş M; Cox K; Devalia H; Jones S; Jones P; Sever AR
Diagn Interv Radiol; 2016; 22(1):29-34. PubMed ID: 26509833
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at Surgery.
Podoll MB; Reisenbichler ES; Roland L; Bruner A; Mizuguchi S; Sanders MAG
Arch Pathol Lab Med; 2018 Sep; 142(9):1120-1126. PubMed ID: 29582675
[TBL] [Abstract][Full Text] [Related]
17. Predicting invasion in mammographically detected microcalcification.
Bagnall MJ; Evans AJ; Wilson AR; Pinder SE; Denley H; Geraghty JG; Ellis IO
Clin Radiol; 2001 Oct; 56(10):828-32. PubMed ID: 11895299
[TBL] [Abstract][Full Text] [Related]
18. Preoperatively diagnosed ductal cancers in situ of the breast presenting as even small masses are of high risk for the invasive cancer foci in postoperative specimen.
Szynglarewicz B; Kasprzak P; Halon A; Matkowski R
World J Surg Oncol; 2015 Jul; 13():218. PubMed ID: 26179898
[TBL] [Abstract][Full Text] [Related]
19. Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ.
Arvold ND; Punglia RS; Hughes ME; Jiang W; Edge SB; Javid SH; Laronga C; Niland JC; Theriault RL; Weeks JC; Wong YN; Lee SJ; Hassett MJ
Cancer; 2012 Dec; 118(24):6022-30. PubMed ID: 22674478
[TBL] [Abstract][Full Text] [Related]
20. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
Sanders ME; Schuyler PA; Dupont WD; Page DL
Cancer; 2005 Jun; 103(12):2481-4. PubMed ID: 15884091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
